Trial to Evaluate Safety, PD & PK of IV Study Drug, QN-302, in Pts w/ Advanced or Metastatic Solid Tumors
Trial to Evaluate Safety, PD & PK of IV Study Drug, QN-302, in Pts w/ Advanced or Metastatic Solid Tumors
Recruiting · NCT06086522 · Registry updated 2024-05-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Trial to Evaluate Safety, PD & PK of IV Study Drug, QN-302, in Pts w/ Advanced or Metastatic Solid Tumors | Solid Tumor | Recruiting | Phase 1 | 2024-05-01 | NCT06086522 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Qualigen Theraputics, Inc. | 1 |
| Translational Drug Development | 3 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| HonorHealth | Scottsdale | United States | 4 |
| MD Anderson Cancer Center | Houston | United States | 1 |
| START Midwest | Grand Rapids | United States | 79 |
| Yale | New Haven | United States | 10 |